# Molecular characteristics of established trophoblast-derived cell lines

- **DOI:** [10.1016/j.placenta.2021.02.022](https://doi.org/10.1016/j.placenta.2021.02.022)
- **Rating:** Sound (3.2 out of 5)
- **Verdict:** Seven-line trophoblast profiling identifies overlapping hybridoma genotypes and guides feature-specific model selection, but its general suitability ranking lacks a direct primary-cell benchmark.
- **Framework version:** v5.13
- **Pipeline version:** v0.4
- **Evaluation date:** 2026-11-13
- **Evaluation page:** https://www.nabu.science/paper/10.1016%2Fj.placenta.2021.02.022

## Key claims

1. In general, characteristics and markers of choriocarcinoma derived cell lines seem to be more similar to in vivo trophoblast than immortalized cell lines and thus might be regarded as more suitable models.
   - Support: Tentative
   - Type: Primary finding
   - Basis: literature-referenced marker comparisons without a contemporaneous primary-trophoblast benchmark cannot establish general model suitability
   - Location: Abstract, Discussion
2. STR patterns retrieved from AC1-M32 and ACH-3P cells were 100% identical and differed from AC1 M59 in only one of all 24 tested systems (DE19S433).
   - Support: Well-supported
   - Type: Secondary
   - Basis: matching STR profiles reproduced across passages and an independent ACH-3P batch directly support identity within the tested marker systems
   - Location: Section 3.3, Table 1
3. Compared to choriocarcinoma-derived cell lines, expression of C19MC and hormone secretion were almost absent in immortalized cell lines. Conversely, they express C14MC and exhibit higher migration and network stabilization.
   - Support: Tentative
   - Type: Secondary
   - Basis: two immortalized lines and undefined functional replicate units limit generalization, while mixed functional rankings contradict the class-wide superiority statement
   - Location: Abstract (Results); Sections 3.4, 3.6–3.8

## Strengths

- **Passage-spanning authentication identifies overlapping hybridoma genotypes** STR profiling across passages and an independent ACH-3P batch identifies matching AC1-M32 and ACH-3P profiles and a one-locus difference from AC1-M59. This provides a concrete basis for scrutinizing the assumed origins of these models.
  - Dimension: contribution
  - Location: Sections 2.6 and 3.3; Table 1
- **Complementary assays characterize seven trophoblast models** The comparison combines mRNA, protein, hormone, miRNA and functional measurements rather than relying on a single marker. Assay identifiers, amplification controls and mycoplasma checks support interpretation of the descriptive profiles.
  - Dimension: methodological rigour
  - Location: Sections 2.3–2.12 and 3.4–3.8; Figures 2–3
- **Discussion engages conflicting trophoblast marker evidence** The discussion addresses conflicting CK7 and HLA-G reports, culture-dependent phenotypes and omitted models. It explicitly recommends confirmation in primary trophoblast or in vivo before drawing pathophysiological conclusions.
  - Dimension: positioning
  - Location: Section 4

## Limitations

- **Abstract rankings exceed the reported comparisons** The Discussion places HTR-8/SVneo above BeWo in network nodes, although Results report 105.1 versus 117.3. The abstract also generalizes functional superiority across immortalized lines and overall suitability across choriocarcinoma-derived models despite mixed results and no direct primary-cell benchmark.
  - Dimension: reporting
  - Location: Abstract; Sections 3.7–3.8; Section 4; Table 2
- **Wound closure does not isolate migration** The 24-hour closure assay is interpreted as migration even though AC1-M32 and ACH-3P also show higher proliferation. Growth can contribute to closure, preventing a clean migration ranking for those lines.
  - Dimension: methodological rigour
  - Location: Sections 2.11 and 3.7; Figure 3A
- **Functional replication and uncertainty remain insufficiently specified** Figure 3 does not establish whether quantitative results summarize independent experiments or technical wells. The absence of inferential testing and dispersion for the reported node counts further limits assessment of functional differences.
  - Dimension: methodological rigour
  - Location: Sections 3.7–3.8; Figure 3 legend

## Reliability checks

Caveats (4 of 4 checks).

- **Results check:** Noted
  - Compared to choriocarcinoma-derived cell lines, expression of C19MC and hormone secretion were almost absent in immortalized cell lines. Conversely, they express C14MC and exhibit higher migration and network stabilization: "Conversely, they express C14MC and exhibit higher migration and network stabilization." (Abstract; Section 3.7, migration) vs "Swan71, ACH-3P and AC1-M32 showed a noticeably higher migration potential with faster closure rates compared to the other tested cell lines." (Section 3.7). The Results identify one immortalized line, Swan71, and two hybridoma lines as faster closing, rather than both immortalized lines. → Changes the size materially
  - Network stabilization properties in co-culture with endothelial cells revealed higher node building numbers in Swan71 and HTR-8/SVneo cells than in JEG-3 and BeWo cells: "Network stabilization properties in co-culture with endothelial cells revealed higher node building numbers in Swan71 and HTR-8/SVneo cells than in JEG-3 and BeWo cells." (Section 4, network stabilization discussion) vs "Swan71 cells showed the highest number of nodes (141.6) followed by BeWo, HTR-8/SVneo and JEG-3 cells (117.3, 105.1 and 100.8, respectively)." (Section 3.8). HTR-8/SVneo has 105.1 − 117.3 = −12.2 nodes relative to BeWo, contradicting the stated higher-node comparison. → Not supported by the paper's own data
  - Immortalized cell lines differ from choriocarcinoma-derived ones in the expression of HLA-G, E-cadherin, N-cadherin, VE-cadherin, cadherin-11, cytokeratin 7, vimentin, ADAM12 and PRG2: "Vimentin and N-cadherin were exclusively expressed in HTR-8/SVneo and Swan71 cells." (Section 3.5, vimentin and N-cadherin) vs "only in low levels by BeWo (vimentin) and the AC1-M32, AC1-M59 and ACH-3P cell lines (N-cadherin)" (Section 4, mesenchymal markers paragraph). The Discussion reports low expression outside the two immortalized lines, contradicting exclusivity but not the broader expression contrast. → Conclusion holds
  - Compared to choriocarcinoma-derived cell lines, expression of C19MC and hormone secretion were almost absent in immortalized cell lines. Conversely, they express C14MC and exhibit higher migration and network stabilization: "Cell migration was assessed using Ibidi™ culture inserts" (Section 2.11, migration assay) vs "were tested using the xCELLigence® Real-Time Cell Analyzer system" (Fig. 3A legend). Methods specify an insert-based wound-healing assay, whereas the Figure 3A caption attributes migration to xCELLigence. → Effect on result unclear
  - Compared to choriocarcinoma-derived cell lines, expression of C19MC and hormone secretion were almost absent in immortalized cell lines. Conversely, they express C14MC and exhibit higher migration and network stabilization: "C14MC (has-miR-127–3p, assay ID: 477889_mir; has-miR-411–5p, Assay ID: 478086_mir; has-miR-655–3p, Assay ID: 478191_mir)" (Section 2.7) vs "Swan71 cells expressed high levels of all five tested C14MC miRNAs, while in HTR-8/SVneo cells only three miRNAs were detected at lower levels." (Section 3.6). Methods enumerate three C14MC assays, whereas Results refer to five tested C14MC miRNAs. → Conclusion holds
  - Minor reporting notes (2):
    - Descriptive: "a unique profile was reported for each given cell line excluding cross-contamination" (Section 4, STR authentication) vs "ACH-3P can be considered genotypically equal to AC1-M32 and AC1-M59 in the tested marker systems" (Section 4, STR authentication). The universal uniqueness statement conflicts with the matching hybridoma profiles reported in the same discussion and Table 1. → Conclusion holds
    - Descriptive: "all 24 tested systems (DE19S433)." (Section 3.3) vs "| D16S539 | 13, 14 | 13, 14 | 13 |" (Table 1, rows 5 and 17). Table 1 contains 24 STR rows but duplicates D16S539, leaving 23 unique STR loci plus Amelogenin, consistent with 24 total systems rather than 24 unique STR loci plus Amelogenin. → Conclusion holds
- **Reporting and transparency:** Noted. The secondary-antibody list does not account for the reported rabbit primary antibodies. A conflict-of-interest declaration is present, and the established-cell-line design does not require a new human or animal ethics approval.
  - Conflict of interest: declared · Data availability: not stated · Code availability: not stated
- **Reference integrity:** Noted
  - 76 references in manuscript
  - 74 of 76 checkable references found in an index
  - 8 mistyped DOIs matched to the cited work by its details
  - Title diverges from identifier for 1 reference:
    - C.D. MacCalman, E.E. Furth, A. Omigbodun, M. Bronner, C. Coutifaris, J.F. Strauss, Regulated expression of cadherin-11 in human epithelial cells: a role for cadherin-11 in trophoblast-endometrium interactions? Dev. Dynam. (1996) https://doi.org/10.1002/(SICI)1097-0177(199606)200:2<201::AID-AJA9>3.0.CO;2-M. (Cited DOI resolves in no index (Crossref, DataCite) and no matching work found by title search — the identifier was never minted and the work itself cannot be located. Flagged for manual review.)
  - Could not be verified automatically — queued for manual review:
    - R.A. Pattillo, G.O. Gey, The Establishment of a Cell Line of Human Hormone-Synthesizing Trophoblastic Cells in Vitro, Cancer Res., 1968. (Ambiguous: title ratio 0.52 via crossref_bibliographic sits between the divergence (0.30) and match (0.70) thresholds; too close to call either way, so it is recorded as unresolved rather than judged.)
  - Citation details diverge for 1 reference:
    - #4 M. Gauster, B. Huppertz, Fusion of cytochrophoblast with syncytiotrophoblast in the human placenta: factors involved in syncytialization, J. Reprod. Med. Endocrinol. 5 (2008) 76–82, https://doi.org/10.1007/978-3-540-79319-9_12. (DOI resolves to: “Endokrinologie” (Anatomie und Physiologie — Arbeitsbuch). Differs from the DOI’s record on: container, title) https://doi.org/10.1007/978-3-540-79319-9_12
  - References not verified automatically are resolved manually within 24 hours.

## Post-publication record

- **Status:** Clean
- **Summary:** No retraction or expression of concern found in Crossref (includes Retraction Watch).
- **Last checked:** 2026-11-13
